Sales grew 3.6% like-for-like in H1 2026, with strong Fragrance & Beauty momentum and sequential recovery in Taste & Wellbeing. Adjusted EBITDA margin was 24.3%, impacted by non-recurring costs, while the outlook remains positive with confidence in achieving 2030 targets.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.